Mesoporous Silica-Loaded PCL-CHT Hybrid Membranes for Skin Regeneration

An innovative multifunctional membrane, combining polymeric materials with inorganic nanoparticles and bioactive molecules, was developed for skin tissue application. The strategy was to synthesize a hybrid polymeric/silica membrane in which SiO<sub>2</sub> nanoparticles are dispersed inside the membrane matrix. To this end, hexagonal calcined mesoporous silica nanoparticles (MSNs) with a uniform structure, 187.6 ± 4.6 nm diameter, and 5.1 nm pore size were synthesized to accommodate molecules of pharmaceutical interest in the silica mesopores. MSNs were then loaded with daidzein, a prominent isoflavone well-known for its anti-inflammatory, antioxidant, and antidiabetic activity, through chemical-physical interactions to investigate its role as a drug carrier. The hybrid membranes were created by combining chitosan (CHT) and polycaprolactone (PCL) polymers with mesoporous silica nanoparticles, optimizing the polymer-to-silica molar ratio up to 5:1, for which enhanced hydrophilicity (WCA = 55.5 ± 2.9°), moisture permeability (WVTR = 32.2 ± 4.4 g/m<sup>2</sup>·h), and swelling capacity (68 ± 11%) were achieved. Drug release studies on the hybrid membrane incorporating daidzein-preloaded silica confirmed sustained delivery of the active compound, releasing 88.9 ± 0.9 μM/cm<sup>2</sup> after 48 hours. The physical-chemical and morphological-structural properties of the membranes favored the adhesion and growth of human keratinocytes, providing biomimetic cues to facilitate epidermal maturation. In the developed epidermal models, oxygen consumption, which is representative of an active cellular metabolic state, rises over time, leveling off at day 7. The highest oxygen uptake activity was observed in the hybrid membrane PCL-CHT/MSN, achieving values of 161 ± 3 μmol/L at day 11. Hybrid epidermal-membrane constructs enhance keratinocyte proliferation and differentiation, as evidenced by specific cytokeratins, matrix metalloproteinases, and cyclin D1 expression, suggesting improved stratification and epidermal remodeling.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2025-08-11
DOI
https://doi.org/10.1021/acsami.5c09164
Citations
3
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
2.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mesoporous Silica-Loaded PCL-CHT Hybrid Membranes for Skin Regeneration

Catia Morelli, Marzia De Santo, Loredana De Bartolo, Luigi Pasqua et al.
3 citations
ACS Applied Materials & Interfaces
Advancements in Transdermal Drug Delivery
2.37
article

Mesoporous Silica-Loaded PCL-CHT Hybrid Membranes for Skin Regeneration

Catia Morelli, Marzia De Santo, Loredana De Bartolo, Luigi Pasqua, Simona Salerno, Francesca Giordano, A. Spadafora, Sabrina Morelli, Antonella Leggio, Gianluca Dell’olio, Camilla Longobucco, Andrea Vardè
article en
3 citations

Abstract

An innovative multifunctional membrane, combining polymeric materials with inorganic nanoparticles and bioactive molecules, was developed for skin tissue application. The strategy was to synthesize a hybrid polymeric/silica membrane in which SiO<sub>2</sub> nanoparticles are dispersed inside the membrane matrix. To this end, hexagonal calcined mesoporous silica nanoparticles (MSNs) with a uniform structure, 187.6 ± 4.6 nm diameter, and 5.1 nm pore size were synthesized to accommodate molecules of pharmaceutical interest in the silica mesopores. MSNs were then loaded with daidzein, a prominent isoflavone well-known for its anti-inflammatory, antioxidant, and antidiabetic activity, through chemical-physical interactions to investigate its role as a drug carrier. The hybrid membranes were created by combining chitosan (CHT) and polycaprolactone (PCL) polymers with mesoporous silica nanoparticles, optimizing the polymer-to-silica molar ratio up to 5:1, for which enhanced hydrophilicity (WCA = 55.5 ± 2.9°), moisture permeability (WVTR = 32.2 ± 4.4 g/m<sup>2</sup>·h), and swelling capacity (68 ± 11%) were achieved. Drug release studies on the hybrid membrane incorporating daidzein-preloaded silica confirmed sustained delivery of the active compound, releasing 88.9 ± 0.9 μM/cm<sup>2</sup> after 48 hours. The physical-chemical and morphological-structural properties of the membranes favored the adhesion and growth of human keratinocytes, providing biomimetic cues to facilitate epidermal maturation. In the developed epidermal models, oxygen consumption, which is representative of an active cellular metabolic state, rises over time, leveling off at day 7. The highest oxygen uptake activity was observed in the hybrid membrane PCL-CHT/MSN, achieving values of 161 ± 3 μmol/L at day 11. Hybrid epidermal-membrane constructs enhance keratinocyte proliferation and differentiation, as evidenced by specific cytokeratins, matrix metalloproteinases, and cyclin D1 expression, suggesting improved stratification and epidermal remodeling.

ACS Applied Materials & InterfacesVol. 17(33)
Advanced Materials and Devices (United States) (US), Institute on Membrane Technology (IT), University of Calabria (IT)
European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca, European Regional Development Fund, European Social Fund
Openalex Percentile: Top 11%
Advancements in Transdermal Drug Delivery
2.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.